 | • レポートコード：MRC2-11QY01677 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、152ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はインフルエンザ薬のグローバル市場について調査・分析したレポートです。種類別（ザナミビル、オセルタミビルリン酸塩、ペラミビル、その他のインフルエンザ治療薬）市場規模、用途別（大人、子供）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別インフルエンザ薬の競争状況、市場シェア ・世界のインフルエンザ薬市場：種類別市場規模 2015年-2020年（ザナミビル、オセルタミビルリン酸塩、ペラミビル、その他のインフルエンザ治療薬） ・世界のインフルエンザ薬市場：種類別市場規模予測 2021年-2026年（ザナミビル、オセルタミビルリン酸塩、ペラミビル、その他のインフルエンザ治療薬） ・世界のインフルエンザ薬市場：用途別市場規模 2015年-2020年（大人、子供） ・世界のインフルエンザ薬市場：用途別市場規模予測 2021年-2026年（大人、子供） ・北米のインフルエンザ薬市場分析：米国、カナダ ・ヨーロッパのインフルエンザ薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのインフルエンザ薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のインフルエンザ薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのインフルエンザ薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bristol-Myers Squibb]、AstraZeneca、Eli Lilly、Roche、GlaxoSmithKline、Novartis、Pfizer、Sanofi Pasteur、Bayer、Celgene、Seqirus、Protein Sciences Corporation、Serum Institute of India、Emergent Biosolutions、BioCryst Pharmaceuticals、Alvogen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Influenza Drugs Market
The global Influenza Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Influenza Drugs Scope and Market Size
Influenza Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Influenza Drugs market is segmented into
Zanamivir
Oseltamivir Phosphate
Peramivir
Other Influenza Drugs
Segment by Application, the Influenza Drugs market is segmented into
Adults
Chidren
Regional and Country-level Analysis
The Influenza Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Influenza Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Influenza Drugs Market Share Analysis
Influenza Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Influenza Drugs business, the date to enter into the Influenza Drugs market, Influenza Drugs product introduction, recent developments, etc.
The major vendors covered:
Bristol-Myers Squibb]
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
1 Study Coverage
1.1 Influenza Drugs Product Introduction
1.2 Market Segments
1.3 Key Influenza Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Influenza Drugs Market Size Growth Rate by Type
1.4.2 Zanamivir
1.4.3 Oseltamivir Phosphate
1.4.4 Peramivir
1.4.5 Other Influenza Drugs
1.5 Market by Application
1.5.1 Global Influenza Drugs Market Size Growth Rate by Application
1.5.2 Adults
1.5.3 Chidren
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Influenza Drugs Market Size, Estimates and Forecasts
2.1.1 Global Influenza Drugs Revenue 2015-2026
2.1.2 Global Influenza Drugs Sales 2015-2026
2.2 Global Influenza Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Influenza Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Influenza Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Influenza Drugs Competitor Landscape by Players
3.1 Influenza Drugs Sales by Manufacturers
3.1.1 Influenza Drugs Sales by Manufacturers (2015-2020)
3.1.2 Influenza Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Influenza Drugs Revenue by Manufacturers
3.2.1 Influenza Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Influenza Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Influenza Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Influenza Drugs Revenue in 2019
3.2.5 Global Influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Influenza Drugs Price by Manufacturers
3.4 Influenza Drugs Manufacturing Base Distribution, Product Types
3.4.1 Influenza Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Influenza Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Influenza Drugs Market Size by Type (2015-2020)
4.1.1 Global Influenza Drugs Sales by Type (2015-2020)
4.1.2 Global Influenza Drugs Revenue by Type (2015-2020)
4.1.3 Influenza Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Influenza Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Influenza Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Influenza Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Influenza Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Influenza Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Influenza Drugs Market Size by Application (2015-2020)
5.1.1 Global Influenza Drugs Sales by Application (2015-2020)
5.1.2 Global Influenza Drugs Revenue by Application (2015-2020)
5.1.3 Influenza Drugs Price by Application (2015-2020)
5.2 Influenza Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Influenza Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Influenza Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Influenza Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Influenza Drugs by Country
6.1.1 North America Influenza Drugs Sales by Country
6.1.2 North America Influenza Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Influenza Drugs Market Facts & Figures by Type
6.3 North America Influenza Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Influenza Drugs by Country
7.1.1 Europe Influenza Drugs Sales by Country
7.1.2 Europe Influenza Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Influenza Drugs Market Facts & Figures by Type
7.3 Europe Influenza Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Influenza Drugs by Region
8.1.1 Asia Pacific Influenza Drugs Sales by Region
8.1.2 Asia Pacific Influenza Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Influenza Drugs Market Facts & Figures by Type
8.3 Asia Pacific Influenza Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Influenza Drugs by Country
9.1.1 Latin America Influenza Drugs Sales by Country
9.1.2 Latin America Influenza Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Influenza Drugs Market Facts & Figures by Type
9.3 Central & South America Influenza Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Influenza Drugs by Country
10.1.1 Middle East and Africa Influenza Drugs Sales by Country
10.1.2 Middle East and Africa Influenza Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Influenza Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Influenza Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Bristol-Myers Squibb]
11.1.1 Bristol-Myers Squibb] Corporation Information
11.1.2 Bristol-Myers Squibb] Description and Business Overview
11.1.3 Bristol-Myers Squibb] Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb] Influenza Drugs Products Offered
11.1.5 Bristol-Myers Squibb] Related Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Description and Business Overview
11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Influenza Drugs Products Offered
11.2.5 AstraZeneca Related Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Description and Business Overview
11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly Influenza Drugs Products Offered
11.3.5 Eli Lilly Related Developments
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Description and Business Overview
11.4.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Roche Influenza Drugs Products Offered
11.4.5 Roche Related Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Description and Business Overview
11.5.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GlaxoSmithKline Influenza Drugs Products Offered
11.5.5 GlaxoSmithKline Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description and Business Overview
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis Influenza Drugs Products Offered
11.6.5 Novartis Related Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Description and Business Overview
11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Pfizer Influenza Drugs Products Offered
11.7.5 Pfizer Related Developments
11.8 Sanofi Pasteur
11.8.1 Sanofi Pasteur Corporation Information
11.8.2 Sanofi Pasteur Description and Business Overview
11.8.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Pasteur Influenza Drugs Products Offered
11.8.5 Sanofi Pasteur Related Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Description and Business Overview
11.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bayer Influenza Drugs Products Offered
11.9.5 Bayer Related Developments
11.10 Celgene
11.10.1 Celgene Corporation Information
11.10.2 Celgene Description and Business Overview
11.10.3 Celgene Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Celgene Influenza Drugs Products Offered
11.10.5 Celgene Related Developments
11.1 Bristol-Myers Squibb]
11.1.1 Bristol-Myers Squibb] Corporation Information
11.1.2 Bristol-Myers Squibb] Description and Business Overview
11.1.3 Bristol-Myers Squibb] Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb] Influenza Drugs Products Offered
11.1.5 Bristol-Myers Squibb] Related Developments
11.12 Protein Sciences Corporation
11.12.1 Protein Sciences Corporation Corporation Information
11.12.2 Protein Sciences Corporation Description and Business Overview
11.12.3 Protein Sciences Corporation Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Protein Sciences Corporation Products Offered
11.12.5 Protein Sciences Corporation Related Developments
11.13 Serum Institute of India
11.13.1 Serum Institute of India Corporation Information
11.13.2 Serum Institute of India Description and Business Overview
11.13.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Serum Institute of India Products Offered
11.13.5 Serum Institute of India Related Developments
11.14 Emergent Biosolutions
11.14.1 Emergent Biosolutions Corporation Information
11.14.2 Emergent Biosolutions Description and Business Overview
11.14.3 Emergent Biosolutions Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Emergent Biosolutions Products Offered
11.14.5 Emergent Biosolutions Related Developments
11.15 BioCryst Pharmaceuticals
11.15.1 BioCryst Pharmaceuticals Corporation Information
11.15.2 BioCryst Pharmaceuticals Description and Business Overview
11.15.3 BioCryst Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.15.4 BioCryst Pharmaceuticals Products Offered
11.15.5 BioCryst Pharmaceuticals Related Developments
11.16 Alvogen
11.16.1 Alvogen Corporation Information
11.16.2 Alvogen Description and Business Overview
11.16.3 Alvogen Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Alvogen Products Offered
11.16.5 Alvogen Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Influenza Drugs Market Estimates and Projections by Region
12.1.1 Global Influenza Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Influenza Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Influenza Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Influenza Drugs Sales Forecast (2021-2026)
12.2.2 North America: Influenza Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Influenza Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Influenza Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Influenza Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Influenza Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Influenza Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Influenza Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Influenza Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Influenza Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Influenza Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Influenza Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Influenza Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Influenza Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Influenza Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Influenza Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Influenza Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Influenza Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Influenza Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Influenza Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Influenza Drugs Market Segments
Table 2. Ranking of Global Top Influenza Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Influenza Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Zanamivir
Table 5. Major Manufacturers of Oseltamivir Phosphate
Table 6. Major Manufacturers of Peramivir
Table 7. Major Manufacturers of Other Influenza Drugs
Table 8. Global Influenza Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Influenza Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Influenza Drugs Sales by Regions 2015-2020 (K MT)
Table 11. Global Influenza Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Influenza Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Influenza Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Influenza Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Influenza Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Influenza Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Drugs as of 2019)
Table 17. Influenza Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Influenza Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Influenza Drugs Price (2015-2020) (USD/MT)
Table 20. Influenza Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Influenza Drugs Product Type
Table 22. Date of International Manufacturers Enter into Influenza Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Influenza Drugs Sales by Type (2015-2020) (K MT)
Table 25. Global Influenza Drugs Sales Share by Type (2015-2020)
Table 26. Global Influenza Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Influenza Drugs Revenue Share by Type (2015-2020)
Table 28. Influenza Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Influenza Drugs Sales by Application (2015-2020) (K MT)
Table 30. Global Influenza Drugs Sales Share by Application (2015-2020)
Table 31. North America Influenza Drugs Sales by Country (2015-2020) (K MT)
Table 32. North America Influenza Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Influenza Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Influenza Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Influenza Drugs Sales by Type (2015-2020) (K MT)
Table 36. North America Influenza Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Influenza Drugs Sales by Application (2015-2020) (K MT)
Table 38. North America Influenza Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Influenza Drugs Sales by Country (2015-2020) (K MT)
Table 40. Europe Influenza Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Influenza Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Influenza Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Influenza Drugs Sales by Type (2015-2020) (K MT)
Table 44. Europe Influenza Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Influenza Drugs Sales by Application (2015-2020) (K MT)
Table 46. Europe Influenza Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Influenza Drugs Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Influenza Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Influenza Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Influenza Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Influenza Drugs Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Influenza Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Influenza Drugs Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Influenza Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Influenza Drugs Sales by Country (2015-2020) (K MT)
Table 56. Latin America Influenza Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Influenza Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Influenza Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Influenza Drugs Sales by Type (2015-2020) (K MT)
Table 60. Latin America Influenza Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Influenza Drugs Sales by Application (2015-2020) (K MT)
Table 62. Latin America Influenza Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Influenza Drugs Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Influenza Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Influenza Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Influenza Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Influenza Drugs Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Influenza Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Influenza Drugs Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Influenza Drugs Sales Market Share by Application (2015-2020)
Table 71. Bristol-Myers Squibb] Corporation Information
Table 72. Bristol-Myers Squibb] Description and Major Businesses
Table 73. Bristol-Myers Squibb] Influenza Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. Bristol-Myers Squibb] Product
Table 75. Bristol-Myers Squibb] Recent Development
Table 76. AstraZeneca Corporation Information
Table 77. AstraZeneca Description and Major Businesses
Table 78. AstraZeneca Influenza Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. AstraZeneca Product
Table 80. AstraZeneca Recent Development
Table 81. Eli Lilly Corporation Information
Table 82. Eli Lilly Description and Major Businesses
Table 83. Eli Lilly Influenza Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Eli Lilly Product
Table 85. Eli Lilly Recent Development
Table 86. Roche Corporation Information
Table 87. Roche Description and Major Businesses
Table 88. Roche Influenza Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Roche Product
Table 90. Roche Recent Development
Table 91. GlaxoSmithKline Corporation Information
Table 92. GlaxoSmithKline Description and Major Businesses
Table 93. GlaxoSmithKline Influenza Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. GlaxoSmithKline Product
Table 95. GlaxoSmithKline Recent Development
Table 96. Novartis Corporation Information
Table 97. Novartis Description and Major Businesses
Table 98. Novartis Influenza Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Novartis Product
Table 100. Novartis Recent Development
Table 101. Pfizer Corporation Information
Table 102. Pfizer Description and Major Businesses
Table 103. Pfizer Influenza Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Pfizer Product
Table 105. Pfizer Recent Development
Table 106. Sanofi Pasteur Corporation Information
Table 107. Sanofi Pasteur Description and Major Businesses
Table 108. Sanofi Pasteur Influenza Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Sanofi Pasteur Product
Table 110. Sanofi Pasteur Recent Development
Table 111. Bayer Corporation Information
Table 112. Bayer Description and Major Businesses
Table 113. Bayer Influenza Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Bayer Product
Table 115. Bayer Recent Development
Table 116. Celgene Corporation Information
Table 117. Celgene Description and Major Businesses
Table 118. Celgene Influenza Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Celgene Product
Table 120. Celgene Recent Development
Table 121. Seqirus Corporation Information
Table 122. Seqirus Description and Major Businesses
Table 123. Seqirus Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Seqirus Product
Table 125. Seqirus Recent Development
Table 126. Protein Sciences Corporation Corporation Information
Table 127. Protein Sciences Corporation Description and Major Businesses
Table 128. Protein Sciences Corporation Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. Protein Sciences Corporation Product
Table 130. Protein Sciences Corporation Recent Development
Table 131. Serum Institute of India Corporation Information
Table 132. Serum Institute of India Description and Major Businesses
Table 133. Serum Institute of India Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 134. Serum Institute of India Product
Table 135. Serum Institute of India Recent Development
Table 136. Emergent Biosolutions Corporation Information
Table 137. Emergent Biosolutions Description and Major Businesses
Table 138. Emergent Biosolutions Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 139. Emergent Biosolutions Product
Table 140. Emergent Biosolutions Recent Development
Table 141. BioCryst Pharmaceuticals Corporation Information
Table 142. BioCryst Pharmaceuticals Description and Major Businesses
Table 143. BioCryst Pharmaceuticals Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 144. BioCryst Pharmaceuticals Product
Table 145. BioCryst Pharmaceuticals Recent Development
Table 146. Alvogen Corporation Information
Table 147. Alvogen Description and Major Businesses
Table 148. Alvogen Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 149. Alvogen Product
Table 150. Alvogen Recent Development
Table 151. Global Influenza Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 152. Global Influenza Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 153. Global Influenza Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 154. Global Influenza Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 155. North America: Influenza Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 156. North America: Influenza Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 157. Europe: Influenza Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 158. Europe: Influenza Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 159. Asia Pacific: Influenza Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 160. Asia Pacific: Influenza Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 161. Latin America: Influenza Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 162. Latin America: Influenza Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 163. Middle East and Africa: Influenza Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 164. Middle East and Africa: Influenza Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 165. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 166. Key Challenges
Table 167. Market Risks
Table 168. Main Points Interviewed from Key Influenza Drugs Players
Table 169. Influenza Drugs Customers List
Table 170. Influenza Drugs Distributors List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Drugs Product Picture
Figure 2. Global Influenza Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Zanamivir Product Picture
Figure 4. Oseltamivir Phosphate Product Picture
Figure 5. Peramivir Product Picture
Figure 6. Other Influenza Drugs Product Picture
Figure 7. Global Influenza Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Adults
Figure 9. Chidren
Figure 10. Influenza Drugs Report Years Considered
Figure 11. Global Influenza Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Influenza Drugs Sales 2015-2026 (K MT)
Figure 13. Global Influenza Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Influenza Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Influenza Drugs Sales Market Share by Region in 2019
Figure 16. Global Influenza Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Influenza Drugs Revenue Market Share by Region in 2019
Figure 18. Global Influenza Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Influenza Drugs Revenue in 2019
Figure 20. Influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Influenza Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Influenza Drugs Sales Market Share by Type in 2019
Figure 23. Global Influenza Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Influenza Drugs Revenue Market Share by Type in 2019
Figure 25. Global Influenza Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Influenza Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Influenza Drugs Sales Market Share by Application in 2019
Figure 28. Global Influenza Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Influenza Drugs Revenue Market Share by Application in 2019
Figure 30. North America Influenza Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Influenza Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Influenza Drugs Sales Market Share by Country in 2019
Figure 33. North America Influenza Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Influenza Drugs Market Share by Type in 2019
Figure 39. North America Influenza Drugs Market Share by Application in 2019
Figure 40. Europe Influenza Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Influenza Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Influenza Drugs Sales Market Share by Country in 2019
Figure 43. Europe Influenza Drugs Revenue Market Share by Country in 2019
Figure 44. Germany Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Influenza Drugs Market Share by Type in 2019
Figure 55. Europe Influenza Drugs Market Share by Application in 2019
Figure 56. Asia Pacific Influenza Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Influenza Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Influenza Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific Influenza Drugs Revenue Market Share by Region in 2019
Figure 60. China Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Influenza Drugs Market Share by Type in 2019
Figure 83. Asia Pacific Influenza Drugs Market Share by Application in 2019
Figure 84. Latin America Influenza Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Influenza Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Influenza Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Influenza Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Influenza Drugs Market Share by Type in 2019
Figure 95. Latin America Influenza Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa Influenza Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Influenza Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Influenza Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Influenza Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Influenza Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Influenza Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Influenza Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa Influenza Drugs Market Share by Application in 2019
Figure 108. North America Influenza Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Influenza Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Influenza Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Influenza Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Influenza Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Influenza Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Influenza Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Influenza Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Influenza Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Influenza Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
インフルエンザ診断の世界市場（～2026年） Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B viru…- インフルエンザ治療薬の世界市場（～2026年） Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disor…
- インフルエンザワクチン接種の世界市場（～2026年） Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, …
- 犬用インフルエンザワクチンの世界市場（～2026年） Market Analysis and Insights: Global Canine Influenza Vaccine Market The global Canine Influenza Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Canine Influenza Vaccine Scope and Market Size Canine Influenza V…
- 馬インフルエンザワクチンの世界市場（～2026年） Market Analysis and Insights: Global Equine Influenza Vaccine Market The global Equine Influenza Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Equine Influenza Vaccine Scope and Market Size Equine Influenza V…